About Plexiform Biosciences
Plexiform Biosciences is a private company based in Dover, Delaware, incorporated in 2024 in Delaware. It has reported $1,340,000 raised in one offering on Form D since December 2024. Its chief executive is Saad Ahmad.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 3, 2024 | Dec 17, 2024amended Jul 18, 2025 | $1,340,000of $2.2M target | 14 | $95,714 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Plexiform Biosciences's Form D filed Jul 18, 2025.
%20copy%20(2).png)
Saad Ahmad
Founder & CEO
On every Form D that Plexiform Biosciences has filed: 2 filings, from Dec 17, 2024 to Jul 18, 2025.
